tiprankstipranks
Trending News
More News >
Biostar (BSPM)
:BSPM
US Market

Biostar Pharmaceuticals (BSPM) Income Statement

Compare
53 Followers

Biostar Pharmaceuticals Income Statement

Last quarter (Q3 2017), Biostar Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Biostar Pharmaceuticals's net income was $-654.86K. See Biostar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 16Dec 15Dec 14Dec 13Dec 12
Total Revenue
$ 2.38M$ 27.13M$ 61.42M$ 52.73M$ 49.32M
Gross Profit
$ 915.17K$ 11.10M$ 30.28M$ 25.68M$ 29.85M
Operating Expenses
$ 4.48M$ 21.98M$ 28.97M$ 24.60M$ 41.99M
Depreciation and Amortization
$ 1.14M$ 2.24M$ 3.09M$ 2.79M$ 2.12M
EBITDA
$ -1.70M$ -21.19M$ 4.39M$ 3.54M$ -21.49M
Operating Income
$ -3.56M$ -10.87M$ 2.64M$ 2.43M$ -12.14M
Other Income/Expenses
$ 518.93K$ -35.15K$ 2.85M$ 230.86K$ -1.39M
Pretax Income
$ -3.05M$ -23.79M$ 1.53M$ 2.66M$ -21.57M
Net Income
$ -5.70M$ -25.11M$ 4.85M$ 809.05K$ -20.00M
Per Share Metrics
Basic EPS
$ -2.48$ -11.36$ 2.30$ 0.49$ -14.63
Diluted EPS
$ -2.48$ -11.36$ 2.30$ 0.49$ -14.63
Weighted Average Shares Outstanding
2.30M 2.21M 2.07M 1.64M 1.37M
Weighted Average Shares Outstanding (Diluted)
2.30M 2.21M 2.07M 1.64M 1.37M
Currency in USD

Biostar Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis